Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

Three cases of Human Metapneumovirus (HMPV) have been detected in India - two in Bengaluru and one in Ahmedabad. The cases were detected in babies and one of them has been discharged from the ...

NEW DELHI: The National Technical Advisory Group on Immunization (NTAGI) has approved the Serum Institute’s Covid-19 Covovax for the 12-17 age group. But, no decision has been taken on ...

The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group.

New Delhi: The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults ...

Now, Covovax, known abroad as Novovax, has already been cleared by the WHO and the EU. Second, according to multiple newspaper reports, there is no shortage of Covovax.

Covovax is the Indian version of the Novovax vaccine. In its clinical trials, the Novovax COVID vaccine showed an overall efficacy rate of 89.7%.

New Delhi: Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and ...

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research here.

India's drug regulator in July had granted permission to Serum Institute of India (SII) for conducting a phase 2/3 trial of Covovax on children aged 2 to 17 years with certain conditions on the ...